» Drug, Devices, and Supplements
» Physician Accountability
» Consumer Product Safety
» Worker Safety
» Health Care Delivery
» Auto and Truck Safety
» Global Access to Medicines
» Infant Formula Marketing
September 5, 2012
View lawsuit as PDF.
View press release.
November 6, 2012, FDA Rejection of Public Citizen Petition to Ban Aricept 23
November 6, 2012 - Press release: FDA Rejects Petition to Ban Aricept 23: Did Drug Companies, FDA Collude in Approving Dangerous Alzheimer’s Drug?
Public Citizen files suit to compel The Food and Drug Administration (FDA) to act on our petition calling on the agency to stop allowing the drug Aricept to be marketed at doses that can cause severe – and even fatal – side effects.
Copyright © 2017 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.
You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.
Public Citizen lobbies Congress
and federal agencies to advance Public Citizen’s mission of advancing
government and corporate accountability. When you make a contribution to Public
Citizen, you become a member of Public Citizen, showing your support and entitling
you to benefits such as Public Citizen
News. Contributions to Public Citizen are not tax-deductible.
Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.